According to Zhitong Finance App News, First Pharmaceutical (600833.SH) disclosed its report for the first quarter of 2024. The company achieved revenue of 462 million yuan during the reporting period, an increase of 0.65% over the previous year. Net profit attributable to shareholders of listed companies was RMB 3.6538 million, an increase of 21.75% over the previous year. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was RMB 4.4451 million, a year-on-year decrease of 43.55%. Basic earnings per share were 0.1616 yuan/share.